Establishment Labs Holdings Inc.

NASDAQ:ESTA

Medical - Devices

Healthcare
$70.80 +3.21%

+$2.65 today

Market cap
$2.11B
Beta
1.11
P/E (TTM)
-57.6
EPS (TTM)
-$1.48
52W Low $33.35High $86.00

Volume 0.38M

Average 0.50M

ESTA Interest Income

Income earned on cash, deposits, and investments held by the company.

Establishment Labs Holdings Inc.NASDAQ: ESTA

Interest Income · Q3 FY2026 · quarter ended Sep 2026

Interest income declines year over year

Q3 FY2026 interest income of $45K fell 6.3% year over year, ahead of the -76.0% change in trailing-twelve-month interest income. Sequentially, it rose 25.0% from the prior quarter. Over 3 fiscal years it compounded at +69.4% a year.

Context

  • Interest income amounted to 0.2% of revenue in FY2025, down 0.7 pp from a year earlier.
  • Interest income increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -6.3% holds above the trailing-twelve-month pace of -76.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$45K+25.0% QoQ
Last fiscal yearDec 2025
$423K-71.4% YoY
LTMSep 2026
$141K-76.0% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.3%——
1 year-71.4%——
3-year CAGR+69.4%——
5-year CAGR——
10-year CAGR——

Interest Income history

USD · from the income statement

Latest · FY2025
423K USD
Year-over-year change
-71.4%
4-year CAGR
+107.1%

Interest Income vs competitors

How ESTA compares with its peers on the latest reported figures

  • ESTA's LTM Sep 2026 interest income of $141K is the 3rd highest of the 4 companies compared; the peer median is $15.08M.
  • Its year-over-year change of -76.0% is the lowest of 3, against a peer median of -17.6%.
  • Interest income amounts to 0.1% of revenue for ESTA, versus a peer median of 0.9%.
ESTA Competitors Peer median
Interest Income for ESTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INMDInMode Ltd.LTM Mar 2026$22.38M -24.9%+90.4%6.0%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$15.08M -10.2%+15.7%0.9%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026$141K -76.0%+69.4%0.1%
TELATELA Bio, Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding ESTA) $15.08M-17.6%+53.1%0.9%

Competitors are the stored peer set for ESTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue126.68M161.7M165.15M166.03M211.08M
Cost of Revenue41.28M55.11M58.17M56.5M64.77M
Gross Profit85.4M106.6M106.98M109.53M146.31M
Gross Margin67.4%65.9%64.8%66.0%69.3%
Research & Development18.32M20.27M26.43M19.71M20.25M
Selling, General & Admin92.23M125.98M145.58M139.81M165.07M
Operating Expenses110.54M146.25M172M159.51M185.32M
Depreciation & Amortization4.12M4.34M4.88M7.58M10.47M
EBITDA(26.53M)(56.73M)(58.31M)(56.22M)(22.29M)
EBITDA Margin-20.9%-35.1%-35.3%-33.9%-10.6%
Operating Income(25.14M)(39.66M)(65.03M)(49.99M)(39.01M)
Operating Margin-19.8%-24.5%-39.4%-30.1%-18.5%
Interest Income23K87K1.02M1.48M423K
Interest Expense9.06M11.76M15.39M20.83M25.26M
Other Income / Expenses(14.57M)(33.17M)(13.56M)(34.64M)(19.01M)
Income Before Tax(39.71M)(72.82M)(78.58M)(84.63M)(58.02M)
Pre-Tax Margin-31.3%-45.0%-47.6%-51.0%-27.5%
Income Tax Expense1.43M2.39M(81K)(32K)(6.96M)
Net Income(41.14M)(75.21M)(78.5M)(84.6M)(51.06M)
Net Margin-32.5%-46.5%-47.5%-51.0%-24.2%
EPS (Basic)(1.72)(3.08)(3.07)(3.00)(1.72)
EPS (Diluted)(1.72)(3.08)(3.07)(3.00)(1.72)
Weighted Avg Shares23.97M24.46M25.6M28.16M29.62M
Weighted Avg Shares (Diluted)23.97M24.46M25.6M28.16M29.62M

Establishment Labs Holdings Inc.

NASDAQ:ESTA

Intrinsic Alpha fair value

Locked

Current Price

$70.80

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.